Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town
Tóm tắt
Pseudohypoaldosteronism type 1 (PHA1) is a rare genetic disease due to the peripheral resistance to aldosterone. Its clinical spectrum includes neonatal salt loss syndrome with hyponatremia and hypochloraemia, hyperkalemia, metabolic acidosis and increased plasmatic levels of aldosterone. Two genetically distinct forms of disease, renal and systemic, have been described, showing a wide clinical expressivity. Mutations in the genes encoding for the subunits of the epithelial sodium channels (ENaC) are responsible for generalized PHA1. We hereby report on two Italian patients with generalized PHA1, coming from the same small town in the center of Sicily. The first patient is a male child, born from the first pregnancy of healthy consanguineous Sicilian parents. A novel SCNN1A (sodium channel epithelial subunit alpha) gene mutation, inherited from both heterozygous parents, was identified by next generation sequencing (NGS) in the homozygous child (and later, also in the heterozygous maternal aunt). A more detailed family history disclosed a possible related twenty-year-old girl, belonging to the same Sicilian small town, with referred neonatal salt loss syndrome associated to hyperkalemia, and subsequent normal growth and neurodevelopment. This second patient had a PHA1 clinical diagnosis when she was about 1 year old. The genetic investigation was, then, extended to her and to her family, revealing the same mutation in the homozygous girl and in the heterozygous parents. The neonatologist should consider PHA1 diagnosis in newborns showing hyponatremia, hyperkalemia and metabolic acidosis, after the exclusion of a salting-loss form of adrenogenital syndrome. The increased plasmatic levels of aldosterone and aldosterone/renin ratio, associated to a poor response to steroid administration, confirmed the diagnosis in the first present patient. An accurate family history may be decisive to identify the clinical picture. A multidisciplinary approach and close follow-up evaluations are requested, in view of optimal management, adequate growth and development of patients. Next generation sequencing (NGS) techniques allowed the identification of the SCNN1A gene mutation either in both patients or in other heterozygous family members, enabling also primary prevention of disease. Our report may broaden the knowledge of the genetic and molecular bases of PHA1, improving its clinical characterization and providing useful indications for the treatment of patients. Clinical approach must be personalized, also in relation to long-term survival and potential multiorgan complications.
Tài liệu tham khảo
Wang J, Yu T, Yin L, Li J, Yu L, Shen Y, et al. Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1. PLoS One. 2013;8(6):e65676. https://doi.org/10.1371/journal.pone.0065676.
Cheek DB, Perry JV. A salt wasting syndrome in infancy. Arch Dis Child. 1958;33(169):252–6. https://doi.org/10.1136/adc.33.169.252.
Riepe FG. Clinical and molecular features of type 1 pseudohypoaldosteronism. Horm Res. 2009;72(1):1–9. https://doi.org/10.1159/000224334.
Furgeson SB, Linas S. Mechanisms of type I and type II pseudohypoaldosteronism. J Am Soc Nephrol. 2010;21(11):1842–2845. https://doi.org/10.1681/ASN.2010050457.
Manikam L, Cornes MP, Kalra D, Ford C, Gama R. Transient pseudohypoaldosteronism masquerading as congenital adrenal hyperplasia. Ann Clin Biochem. 2011;48(4):380–2. https://doi.org/10.1258/acb.2011.010264.
Schaedel C, Marthinsen L, Kristoffersson AC, Kornfӓlt R, Nilsson KO, Orlenius B, et al. Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel. J Pediatr. 1999;135(6):739–45. https://doi.org/10.1016/S0022-3476(99)70094-6.
World Health Organization. Child growth standards. 2021. https://www.who.int/tools/child-growth-standards/standards.
Adachi M, Tajima T, Muroya K. Dietary potassium restriction attenuates urinary sodium wasting in the generalized form of pseudohypoaldosteronism type 1. CEN Case Rep. 2020;9(3):294. https://doi.org/10.1007/s13730-020-00477-7.
Welzel M, Akin L, Büscher A, Güran T, Hauffa BP, Högler W, et al. Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1. Eur J Endocrinol. 2013;168(5):707–15. https://doi.org/10.1530/EJE-12-1000.
Güran T, Değirmenci S, Bulut İK, Say A, Riepe FG, Güran Ö. Critical points in the management of pseudohypoaldosteronism type 1. J Clin Res Pediatr Endocrinol. 2011;3(2):98–100. https://doi.org/10.4274/jcrpe.v3i2.20.
Eliwa MS, El-Emmawie AH, Saeed MA. Ocular and skin manifestations in systemic pseudohypoaldosteronism. BMJ Case Rep. 2014;2014:bcr2014203741.
Nasir A, Abou NI. Unique eyelid manifestations in type 1 pseudohypoaldosteronism. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F462. https://doi.org/10.1136/archdischild-2011-301339.
Serra G, Corsello G, Antona V, D'Alessandro MM, Cassata N, Cimador M, et al. Autosomal recessive polycystic kidney disease: case report of a newborn with rare PKHD1 mutation, rapid renal enlargement and early fatal outcome. Ital J Pediatr. 2020;46(1):154. https://doi.org/10.1186/s13052-020-00922-4.
Piro E, Serra G, Schierz IAM, Giuffrè M, Corsello G. Neonatal ten-year retrospective study on neural tube defects in a second level university hospital. Ital J Pediatr. 2020;46(1):72. https://doi.org/10.1186/s13052-020-00836-1.
Silva N, Costa M, Silva A, Sá C, Martins S, Antunes A, et al. A case of systemic pseudohypoaldosteronism with a novel mutation in the SCNN1A gene. Endocrinol Nutr. 2013;60(1):33–6. https://doi.org/10.1016/j.endonu.2012.07.002.
Arai K, Tsigos C, Suzuki Y, Irony I, Karl M, Listwak S, et al. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J Clin Endocrinol Metab. 1994;79(4):1019–23. https://doi.org/10.1210/jcem.79.4.7962269.
Shalev H, Ohali M, Abrason O. Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy. J Pediatr. 1994;125(2):246–8. https://doi.org/10.1016/S0022-3476(94)70204-7.
Edelheit O, Hanukoglu I, Gizewska M, Kandemir N, Tenenbaum-Rakover Y, Yurdakök M, et al. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism. Clin Endocrinol. 2005;62(5):547–53. https://doi.org/10.1111/j.1365-2265.2005.02255.x.
Dogan CS, Erdem D, Mesut P, Merve A, Sema A, Iffet B, et al. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism type 1. J Pediatr Endocrinol Metab. 2012;25(9–10):1035–9. https://doi.org/10.1515/jpem-2012-0083.
Piro E, Schierz IAM, Antona V, Pappalardo MP, Giuffrè M, Serra G, et al. Neonatal hyperinsulinemic hypoglycemia: case report of kabuki syndrome due to a novel KMT2D splicing-site mutation. Ital J Pediatr. 2020;46(1):136. https://doi.org/10.1186/s13052-020-00902-8.
Hanukoglu I, Hanukoglu A. Epithelial sodium channel (ENaC) family: phylogeny, structure-function, tissue distribution, and associated inherited diseases. Gene. 2016;579(2):95–132. https://doi.org/10.1016/j.gene.2015.12.061.
Serra G, Antona V, Corsello G, Zara F, Piro E, Falsaperla R. NF1 microdeletion syndrome: case report of two new patients. Ital J Pediatr. 2019;45(1):138. https://doi.org/10.1186/s13052-019-0718-7.
Corsello G, Antona V, Serra G, Zara F, Giambrone C, Lagalla L, et al. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1. Ital J Pediatr. 2018;44(1):45. https://doi.org/10.1186/s13052-018-0483-z.
Serra G, Antona V, Schierz M, Vecchio D, Piro E, Corsello G. Esophageal atresia and Beckwith–Wiedemann syndrome in one of the naturally conceived discordant newborn twins: first report. Clin Case Rep. 2018;6(2):399–401. https://doi.org/10.1002/ccr3.1103.
Liotta A, Maggio MC, Iachininoto R, Bellipanni PF, Calì G, Arena V, et al. Fetal pseudohypoaldosteronism: rare cause of hydramnios. Pediatr Med Chir. 2004;26(2):145–7.
Borghesi A, Mencarelli MA, Memo L, Ferrero GB, Bartuli A, Genuardi M, et al. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant. Ital J Pediatr. 2017;43(1):100.
Piro E, Serra G, Antona V, Giuffrè M, Giorgio E, Sirchia F, et al. Novel LRPPRC compound heterozygous mutation in a child with early-onset Leigh syndrome French-Canadian type: case report of an Italian patient. Ital J Pediatr. 2020;46(1):140. https://doi.org/10.1186/s13052-020-00903-7.